Related Articles
Comparison of the serum fibrin‑fibrinogen degradation products with cytokeratin 19 fragment as biomarkers in patients with lung cancer
SERUM CYTOKERATIN-19 MEASURED BY CYFRA21-1 ASSAY IN PATIENTS WITH GASTROINTESTINAL AND GYNECOLOGIC MALIGNANCY
Evaluation of the soluble fragments of cytokeratin 19 (CK19) in non-small cell lung cancer (NSCLC)
CYFRA 21-1 - A NEW TUMOR-MARKER FOR LUNG-CANCER
Combined use of established and novel tumour markers in the diagnosis of head and neck squamous cell carcinoma